Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Gutierrez-Ramos Jose-Carlos Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Sold 590 shares @ $250.54, valued at $147.8k
06/12/2023 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 20,000 options to buy @ $0.11, valued at $2.2k
05/02/2023 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Sold 500 shares @ $242.1928, valued at $121.1k
05/01/2023 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Granted 1 options to buy @ $236.91, valued at $171.3
02/28/2023 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Paid exercise price by delivering 481 shares @ $249.12, valued at $119.8k
Granted 4,015 shares @ $0
Granted 16,274 options to buy @ $249.12, valued at $4.1M
Granted 10,849 options to buy @ $249.12, valued at $2.7M
02/02/2023 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Granted 461 options to buy @ $267.5, valued at $123.3k
01/30/2023 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Granted options to buy @ $265.98, valued at $43.4
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2022 4 Gutierrez-Ramos Jose-Carlos (SVP, Chief Science Officer) has filed a Form 4 on DANAHER CORP /DE/
Txns: Granted options to buy @ $291.47, valued at $43.1
04/05/2022 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 40,000 options to buy @ $3.36, valued at $134.4k
04/05/2022 3 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 3 on Evelo Biosciences, Inc.
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $60.87, valued at $608.7k
03/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/19/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2020 3 Gutierrez-Ramos Jose-Carlos (SVP, Chief Scientific Officer) has filed a Form 3 on DANAHER CORP /DE/
10/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2020 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Sold 5,734 shares @ $29.1, valued at $166.9k
Sold 4,356 shares @ $29.09, valued at $126.7k
06/21/2019 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Granted 25,000 options to buy @ $12.64, valued at $316k
Exercised 4,356 restricted stock units @ $0
06/14/2019 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 31,380 options to buy @ $7.07, valued at $221.9k
06/14/2019 3 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 3 on Evelo Biosciences, Inc.
06/22/2018 4 Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Granted 8,855 options to buy @ $22.3, valued at $197.5k
Granted 4,356 restricted stock units @ $0
Exercised 5,734 restricted stock units @ $0
03/16/2018 4 Gutierrez-Ramos Jose-Carlos (See Remarks) has filed a Form 4 on SYNLOGIC, INC.
Txns: Granted 120,540 options to buy @ $9.95, valued at $1.2M
08/30/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
06/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/10/2016 3 Guiterrez-Ramos Jose Carlos (Director) has filed a Form 3 on MOMENTA PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy